Pharmavite Moves Into OTCs With Uqora Acquisition To Expand Women’s Health Lineup
Startup Uqora Finds Buyer Four Years After Launch
Executive Summary
Pharmavite acquires Uqora, a startup marketing supplements, OTCs and devices to prevent or treat urinary tract infections. Moving into the category adds a growth driver as UTIs are the most common bacterial infection requiring medical care in the US.
You may also be interested in...
Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line
“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.
Pharmavite's Nurish by Nature Made Subscription Line Extends With Active, Nutrition, Relax Packs
Pharmavite introduces curated, pre-bundled Nurish by Nature Made vitamin lifestyle packs – Active, Relax and Nutrition – containing multivitamins as well as three or four vitamins making each pack unique.
Bridges Consumer Startup Reaches Brands For Specialty Conditions In Clarion Deal
Acquiring Clarion Brands from Swander Pace, Bridges Consumer Healthcare adds portfolio of OTC and supplement brands for symptoms including tinnitus, urinary pain relief and excessive sweating.